The general authorisation of medical cannabis has moved a step closer with the French government granting it temporary status for five years – and scope for this to be renewed indefinitely.
The price, prescription criteria and reimbursement rate are still to be defined.
In the meantime, patients who are already using medical cannabis as part of an experiment will be allowed to continue.